臨床診断薬市場規模、シェア、分析、検査別(肝臓パネル、脂質パネル、腎臓パネル、電解質検査、全血球数、感染症検査、その他)、製品別(試薬、機器、その他)、エンドユーザー別(診断ラボ、病院ラボ、ポイントオブケア検査、その他)、地域別予測、2022-2032年Clinical Diagnostics Market Size, Share, and Analysis, By Test (Liver Panel, Lipid Panel, Renal Panel, Electrolyte Testing, Complete Blood Count, Infectious Disease Testing, Others), By Product (Reagents, Instruments, Others), By End User (Diagnostic Laboratory, Hospital Laboratory, Point-of-care Testing, Others) and Regional Forecasts, 2022-2032 臨床診断薬市場規模、シェア、分析、検査別(肝臓パネル、脂質パネル、腎臓パネル、電解質検査、全血球数、感染症検査、その他)、製品別(試薬、機器、その他)、エンドユーザー別(診断ラボ、病院ラボ、ポイン... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー臨床診断薬市場規模、シェア、分析、検査別(肝臓パネル、脂質パネル、腎臓パネル、電解質検査、全血球数、感染症検査、その他)、製品別(試薬、機器、その他)、エンドユーザー別(診断ラボ、病院ラボ、ポイントオブケア検査、その他)、地域別予測、2022-2032年製品概要 臨床診断市場規模は2021年に668.6億米ドル、予測期間中のCAGRは6.6%を示し、2023年の759億米ドルから2032年には1,355億米ドルに成長すると予測される。 臨床診断サービスは、医師がさまざまな疾患の患者に必要な最善の治療法に関する意思決定を支援するさまざまな手段を提供する。慢性疾患や感染症の頻度は、自動化されたプラットフォームの導入とともに増加しており、市場成長を後押しすると予測されている。臨床診断は、患者の徴候、症状、身体検査を通じて病気を認識、特定、観察するプロセスを示す。多様な疾患を持つ患者の分類とともに、健康と幸福を増進するための疾患管理に役立つ。 市場ハイライト 臨床診断市場は、高血圧、糖尿病、心血管疾患のような疾病に罹患した不健康な習慣を持つ個人のライフスタイルの変化のような要因により、予測期間中にCAGR 6.6%で成長し、1,355億米ドルに達すると予想される。デジタル化の進展により、消費者は臨床結果に関与できるようになり、高い運用コスト削減効果が期待され、予測期間中の市場成長を後押しする。非侵襲的な出生前検査の受け入れの増加は、革新的なナノ材料の実装のための注目を作成し、市場成長のための需要を促進すると予想されるポイントオブケア医療診断。 臨床診断市場セグメント - 検査 o 肝臓パネル o 脂質パネル o 腎臓パネル o 電解質検査 o 完全血球計算 o 感染症検査 o その他 - 製品 o 試薬 機器 o その他 - エンドユーザー 診断ラボ 病院検査室 ポイントオブケア検査 その他 市場ダイナミクス 成長促進要因 臨床診断の需要増加が市場成長を促進する見込み 慢性疾患の罹患率の増加が市場の成長を促進する見込み 抑制要因 分子診断薬の容易な入手が市場の成長を抑制する可能性 主要プレイヤー - バイオメリュー - ARUPラボラトリーズ - ベクトン・ディッキンソン社 - アボットラボラトリーズ - キアゲン - バイオリファレンスラボラトリーズ - ラボコープ - バイオサイエンティア・ヘルスケア - ダナハーコーポレーション - クエスト・ダイアグノスティックス - ホロジック社 - F.ホフマン・ラ・ロシュAG - サーモフィッシャーサイエンティフィック - ソニックヘルスケア - シスメックス株式会社 - シーメンス - その他の著名なプレーヤー(会社概要、事業戦略、主要製品、財務実績、主要業績指標、リスク分析、最近の開発、地域プレゼンス、SWOT分析) 研究室用温度制御ユニットの世界市場はさらに地域別に分類されます: - 北米市場規模、シェア、動向、機会、前年比成長率、CAG.R - 米国、カナダ - 中南米市場規模、シェア、動向、機会、YoY成長率、CAGR - メキシコ、アルゼンチン、ブラジル、中南米の残りの地域 - ヨーロッパ市場規模、シェア、動向、機会、前年比成長率、CAGR - イギリス、フランス、ドイツ、イタリア、スペイン、ベルギー、ハンガリー、ルクセンブルク、オランダ、ポーランド、ノルディック、ロシア、トルコ、その他のヨーロッパ地域 - アジア太平洋地域の市場規模、シェア、動向、機会、前年比成長率、CAGR - インド, 中国, 韓国, 日本, マレーシア, インドネシア, ニュージーランド, オーストラリア, その他の地域 - 中東・アフリカ市場規模、シェア、動向、機会、前年比成長率、CAGR - 北アフリカ、イスラエル、GCC、南アフリカ、その他の地域 本レポートを購入する理由 - 経済的要因および非経済的要因の両方を含むセグメンテーションに基づく市場の定性的および定量的分析 - 各セグメントおよびサブセグメントの市場価値(10億米ドル)データの提供 - 市場の最速成長と支配が期待される地域とセグメントを表示 - 各地域における製品/サービスの消費を強調し、各地域の市場に影響を与えている要因を示す地域別分析 - 主要プレイヤーの市場ランキング、プロファイリングされた企業の過去5年間の新サービス/製品発売、提携、事業拡大、買収を盛り込んだ競争状況 - 主要市場プレイヤーの会社概要、企業洞察、製品ベンチマーク、SWOT分析からなる広範な企業プロフィール - 新興地域と先進地域の両方の成長機会と促進要因、課題と阻害要因を含む最近の動向に関する業界の現在と将来の市場展望 - ポーターのファイブフォース分析による様々な観点からの市場の詳細分析 - バリューチェーンによる市場洞察の提供 - 市場ダイナミクスのシナリオと、今後数年間の市場の成長機会 - 販売後3ヶ月間のアナリストサポート 目次1. Executive Summary1.1.Regional Market Share 1.2. Business Trends 1.3. Clinical Diagnostics Market: COVID-19 Outbreak 1.4.Regional Trends 1.5. Segmentation Snapshot 2. Research Methodology 2.1. Research Objective 2.2.Research Approach 2.3.Data Sourcing and Methodology 2.4. Primary Research 2.5. Secondary Research 2.5.1.Paid Sources 2.5.2. Public Sources 2.6.Market Size Estimation and Data Triangulation 3. Market Characteristics 3.1. Market Definition 3.2.Clinical Diagnostics Market: COVID-19 Impact 3.3.Key Segmentations 3.4. Key Developments 3.5. Allied Industry Data 4. Clinical Diagnostics Market – Industry Insights 4.1.Industry Segmentation 4.2. COVID-19 overview on world economy 4.3. Industry ecosystem Channel analysis 4.4. Innovation & Sustainability 5. Macroeconomic Indicators 6. Recent Developments 7.Market Dynamics 7.1. Introduction 7.2.Growth Drivers 7.3.Market Opportunities 7.4. Market Restraints 7.5.Market Trends 8. Risk Analysis 9. Market Analysis 9.1. Porters Five Forces 9.2.PEST Analysis 9.2.1. Political 9.2.2.Economic 9.2.3.Social 9.2.4.Technological 10. Clinical Diagnostics Market 10.1.Overview 10.2. Historical Analysis (2016-2021) 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast 11.Clinical Diagnostics Market Size & Forecast 2022A-2032F 11.1.Overview 11.2. Key Findings 11.3. Market Segmentation 11.3.1.By Test 11.3.1.1. Liver Panel 11.3.1.1.1. By Value (USD Million) 2022-2032F 11.3.1.1.2.Market Share (%) 2022-2032F 11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F 11.3.1.2.Lipid Panel 11.3.1.2.1.By Value (USD Million) 2022-2032F 11.3.1.2.2. Market Share (%) 2022-2032F 11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.3.Renal Panel 11.3.1.3.1.By Value (USD Million) 2022-2032F 11.3.1.3.2. Market Share (%) 2022-2032F 11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.4.Electrolyte Testing 11.3.1.4.1.By Value (USD Million) 2022-2032F 11.3.1.4.2. Market Share (%) 2022-2032F 11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.5.Complete Blood Count 11.3.1.5.1.By Value (USD Million) 2022-2032F 11.3.1.5.2. Market Share (%) 2022-2032F 11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.6.Infectious Disease Testing 11.3.1.6.1.By Value (USD Million) 2022-2032F 11.3.1.6.2. Market Share (%) 2022-2032F 11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.7.Others 11.3.1.7.1.By Value (USD Million) 2022-2032F 11.3.1.7.2. Market Share (%) 2022-2032F 11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F 11.3.2. By Product 11.3.2.1.Reagents 11.3.2.1.1.By Value (USD Million) 2022-2032F 11.3.2.1.2. Market Share (%) 2022-2032F 11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F 11.3.2.2. Instruments 11.3.2.2.1. By Value (USD Million) 2022-2032F 11.3.2.2.2.Market Share (%) 2022-2032F 11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F 11.3.2.3. Others 11.3.2.3.1. By Value (USD Million) 2022-2032F 11.3.2.3.2.Market Share (%) 2022-2032F 11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F 11.3.3. By End User 11.3.3.1.Diagnostic Laboratory 11.3.3.1.1.By Value (USD Million) 2022-2032F 11.3.3.1.2. Market Share (%) 2022-2032F 11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F 11.3.3.2. Hospital Laboratory 11.3.3.2.1. By Value (USD Million) 2022-2032F 11.3.3.2.2.Market Share (%) 2022-2032F 11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F 11.3.3.3. Point-of-care Testing 11.3.3.3.1. By Value (USD Million) 2022-2032F 11.3.3.3.2.Market Share (%) 2022-2032F 11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F 11.3.3.4. Others 11.3.3.4.1. By Value (USD Million) 2022-2032F 11.3.3.4.2. Market Share (%) 2022-2032F 11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F 12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F 12.1. Overview 12.2. Key Findings 12.3. Market Segmentation 12.3.1. By Test 12.3.2.By Product 12.3.3.By End User 12.4. Country 12.4.1.United States 12.4.2. Canada 13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F 13.1. Overview 13.2. Key Findings 13.3. Market Segmentation 13.3.1. By Test 13.3.2.By Product 13.3.3.By End User 13.4. Country 13.4.1.Germany 13.4.2. United Kingdom 13.4.3. France 13.4.4. Italy 13.4.5. Spain 13.4.6. Russia 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland) 14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F 14.1.Overview 14.2. Key Findings 14.3. Market Segmentation 14.3.1. By Test 14.3.2.By Product 14.3.3.By End User 14.4. Country 14.4.1.India 14.4.2. China 14.4.3. South Korea 14.4.4. Japan 14.4.5. Rest of APAC 15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F 15.1.Overview 15.2. Key Findings 15.3. Market Segmentation 15.3.1. By Test 15.3.2.By Product 15.3.3.By End User 15.4. Country 15.4.1.Israel 15.4.2. GCC 15.4.3. North Africa 15.4.4. South Africa 15.4.5. Rest of Middle East and Africa 16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F 16.1. Overview 16.2. Key Findings 16.3. Market Segmentation 16.3.1. By Test 16.3.2.By Product 16.3.3.By End User 16.4. Country 16.4.1. Mexico 16.4.2. Brazil 16.4.3. Rest of Latin America 17. Competitive Landscape 17.1. Company market share, 2021 17.2.Key player overview 17.3. Key stakeholders 18. Company Profiles 18.1.BioMerieux 18.1.1.Company Overview 18.1.2.Financial Overview 18.1.3.Key Product; Analysis 18.1.4.Company Assessment 18.1.4.1.Product Portfolio 18.1.4.2. Key Clients 18.1.4.3. Market Share 18.1.4.4. Recent News & Development (Last 3 Yrs.) 18.1.4.5. Executive Team 18.2. ARUP Laboratories 18.3. Becton, Dickinson, and Company 18.4.Abbott Laboratories 18.5. Qiagen 18.6. Bio-Reference Laboratories 18.7. Labcorp 18.8.Bioscientia Healthcare 18.9. Danaher Corporation 18.10.Quest Diagnostics Inc. 18.11.Hologic Inc. 18.12.F. Hoffmann-La Roche AG 18.13.Thermo Fisher Scientific 18.14.Sonic Healthcare Ltd 18.15.Sysmex Corporation 18.16. Siemens AG 18.17. Other Prominent Players 19. Appendix 20.Consultant Recommendation 1. Executive Summary 1.1.Regional Market Share 1.2. Business Trends 1.3. Clinical Diagnostics Market: COVID-19 Outbreak 1.4.Regional Trends 1.5. Segmentation Snapshot 2. Research Methodology 2.1. Research Objective 2.2.Research Approach 2.3.Data Sourcing and Methodology 2.4. Primary Research 2.5. Secondary Research 2.5.1.Paid Sources 2.5.2. Public Sources 2.6.Market Size Estimation and Data Triangulation 3. Market Characteristics 3.1. Market Definition 3.2.Clinical Diagnostics Market: COVID-19 Impact 3.3.Key Segmentations 3.4. Key Developments 3.5. Allied Industry Data 4. Clinical Diagnostics Market – Industry Insights 4.1.Industry Segmentation 4.2. COVID-19 overview on world economy 4.3. Industry ecosystem Channel analysis 4.4. Innovation & Sustainability 5. Macroeconomic Indicators 6. Recent Developments 7.Market Dynamics 7.1. Introduction 7.2.Growth Drivers 7.3.Market Opportunities 7.4. Market Restraints 7.5.Market Trends 8. Risk Analysis 9. Market Analysis 9.1. Porters Five Forces 9.2.PEST Analysis 9.2.1. Political 9.2.2.Economic 9.2.3.Social 9.2.4.Technological 10. Clinical Diagnostics Market 10.1.Overview 10.2. Historical Analysis (2016-2021) 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast 11.Clinical Diagnostics Market Size & Forecast 2022A-2032F 11.1.Overview 11.2. Key Findings 11.3. Market Segmentation 11.3.1.By Test 11.3.1.1. Liver Panel 11.3.1.1.1. By Value (USD Million) 2022-2032F 11.3.1.1.2.Market Share (%) 2022-2032F 11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F 11.3.1.2.Lipid Panel 11.3.1.2.1.By Value (USD Million) 2022-2032F 11.3.1.2.2. Market Share (%) 2022-2032F 11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.3.Renal Panel 11.3.1.3.1.By Value (USD Million) 2022-2032F 11.3.1.3.2. Market Share (%) 2022-2032F 11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.4.Electrolyte Testing 11.3.1.4.1.By Value (USD Million) 2022-2032F 11.3.1.4.2. Market Share (%) 2022-2032F 11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.5.Complete Blood Count 11.3.1.5.1.By Value (USD Million) 2022-2032F 11.3.1.5.2. Market Share (%) 2022-2032F 11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.6.Infectious Disease Testing 11.3.1.6.1.By Value (USD Million) 2022-2032F 11.3.1.6.2. Market Share (%) 2022-2032F 11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.7.Others 11.3.1.7.1.By Value (USD Million) 2022-2032F 11.3.1.7.2. Market Share (%) 2022-2032F 11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F 11.3.2. By Product 11.3.2.1.Reagents 11.3.2.1.1.By Value (USD Million) 2022-2032F 11.3.2.1.2. Market Share (%) 2022-2032F 11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F 11.3.2.2. Instruments 11.3.2.2.1. By Value (USD Million) 2022-2032F 11.3.2.2.2.Market Share (%) 2022-2032F 11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F 11.3.2.3. Others 11.3.2.3.1. By Value (USD Million) 2022-2032F 11.3.2.3.2.Market Share (%) 2022-2032F 11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F 11.3.3. By End User 11.3.3.1.Diagnostic Laboratory 11.3.3.1.1.By Value (USD Million) 2022-2032F 11.3.3.1.2. Market Share (%) 2022-2032F 11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F 11.3.3.2. Hospital Laboratory 11.3.3.2.1. By Value (USD Million) 2022-2032F 11.3.3.2.2.Market Share (%) 2022-2032F 11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F 11.3.3.3. Point-of-care Testing 11.3.3.3.1. By Value (USD Million) 2022-2032F 11.3.3.3.2.Market Share (%) 2022-2032F 11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F 11.3.3.4. Others 11.3.3.4.1. By Value (USD Million) 2022-2032F 11.3.3.4.2. Market Share (%) 2022-2032F 11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F 12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F 12.1. Overview 12.2. Key Findings 12.3. Market Segmentation 12.3.1. By Test 12.3.2.By Product 12.3.3.By End User 12.4. Country 12.4.1.United States 12.4.2. Canada 13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F 13.1. Overview 13.2. Key Findings 13.3. Market Segmentation 13.3.1. By Test 13.3.2.By Product 13.3.3.By End User 13.4. Country 13.4.1.Germany 13.4.2. United Kingdom 13.4.3. France 13.4.4. Italy 13.4.5. Spain 13.4.6. Russia 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland) 14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F 14.1.Overview 14.2. Key Findings 14.3. Market Segmentation 14.3.1. By Test 14.3.2.By Product 14.3.3.By End User 14.4. Country 14.4.1.India 14.4.2. China 14.4.3. South Korea 14.4.4. Japan 14.4.5. Rest of APAC 15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F 15.1.Overview 15.2. Key Findings 15.3. Market Segmentation 15.3.1. By Test 15.3.2.By Product 15.3.3.By End User 15.4. Country 15.4.1.Israel 15.4.2. GCC 15.4.3. North Africa 15.4.4. South Africa 15.4.5. Rest of Middle East and Africa 16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F 16.1. Overview 16.2. Key Findings 16.3. Market Segmentation 16.3.1. By Test 16.3.2.By Product 16.3.3.By End User 16.4. Country 16.4.1. Mexico 16.4.2. Brazil 16.4.3. Rest of Latin America 17. Competitive Landscape 17.1. Company market share, 2021 17.2.Key player overview 17.3. Key stakeholders 18. Company Profiles 18.1.BioMerieux 18.1.1.Company Overview 18.1.2.Financial Overview 18.1.3.Key Product; Analysis 18.1.4.Company Assessment 18.1.4.1.Product Portfolio 18.1.4.2. Key Clients 18.1.4.3. Market Share 18.1.4.4. Recent News & Development (Last 3 Yrs.) 18.1.4.5. Executive Team 18.2. ARUP Laboratories 18.3. Becton, Dickinson, and Company 18.4.Abbott Laboratories 18.5. Qiagen 18.6. Bio-Reference Laboratories 18.7. Labcorp 18.8.Bioscientia Healthcare 18.9. Danaher Corporation 18.10.Quest Diagnostics Inc. 18.11.Hologic Inc. 18.12.F. Hoffmann-La Roche AG 18.13.Thermo Fisher Scientific 18.14.Sonic Healthcare Ltd 18.15.Sysmex Corporation 18.16. Siemens AG 18.17. Other Prominent Players 19. Appendix 20.Consultant Recommendation
SummaryClinical Diagnostics Market Size, Share, and Analysis, By Test (Liver Panel, Lipid Panel, Renal Panel, Electrolyte Testing, Complete Blood Count, Infectious Disease Testing, Others), By Product (Reagents, Instruments, Others), By End User (Diagnostic Laboratory, Hospital Laboratory, Point-of-care Testing, Others) and Regional Forecasts, 2022-2032 Table of Contents1. Executive Summary1.1.Regional Market Share 1.2. Business Trends 1.3. Clinical Diagnostics Market: COVID-19 Outbreak 1.4.Regional Trends 1.5. Segmentation Snapshot 2. Research Methodology 2.1. Research Objective 2.2.Research Approach 2.3.Data Sourcing and Methodology 2.4. Primary Research 2.5. Secondary Research 2.5.1.Paid Sources 2.5.2. Public Sources 2.6.Market Size Estimation and Data Triangulation 3. Market Characteristics 3.1. Market Definition 3.2.Clinical Diagnostics Market: COVID-19 Impact 3.3.Key Segmentations 3.4. Key Developments 3.5. Allied Industry Data 4. Clinical Diagnostics Market – Industry Insights 4.1.Industry Segmentation 4.2. COVID-19 overview on world economy 4.3. Industry ecosystem Channel analysis 4.4. Innovation & Sustainability 5. Macroeconomic Indicators 6. Recent Developments 7.Market Dynamics 7.1. Introduction 7.2.Growth Drivers 7.3.Market Opportunities 7.4. Market Restraints 7.5.Market Trends 8. Risk Analysis 9. Market Analysis 9.1. Porters Five Forces 9.2.PEST Analysis 9.2.1. Political 9.2.2.Economic 9.2.3.Social 9.2.4.Technological 10. Clinical Diagnostics Market 10.1.Overview 10.2. Historical Analysis (2016-2021) 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast 11.Clinical Diagnostics Market Size & Forecast 2022A-2032F 11.1.Overview 11.2. Key Findings 11.3. Market Segmentation 11.3.1.By Test 11.3.1.1. Liver Panel 11.3.1.1.1. By Value (USD Million) 2022-2032F 11.3.1.1.2.Market Share (%) 2022-2032F 11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F 11.3.1.2.Lipid Panel 11.3.1.2.1.By Value (USD Million) 2022-2032F 11.3.1.2.2. Market Share (%) 2022-2032F 11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.3.Renal Panel 11.3.1.3.1.By Value (USD Million) 2022-2032F 11.3.1.3.2. Market Share (%) 2022-2032F 11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.4.Electrolyte Testing 11.3.1.4.1.By Value (USD Million) 2022-2032F 11.3.1.4.2. Market Share (%) 2022-2032F 11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.5.Complete Blood Count 11.3.1.5.1.By Value (USD Million) 2022-2032F 11.3.1.5.2. Market Share (%) 2022-2032F 11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.6.Infectious Disease Testing 11.3.1.6.1.By Value (USD Million) 2022-2032F 11.3.1.6.2. Market Share (%) 2022-2032F 11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.7.Others 11.3.1.7.1.By Value (USD Million) 2022-2032F 11.3.1.7.2. Market Share (%) 2022-2032F 11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F 11.3.2. By Product 11.3.2.1.Reagents 11.3.2.1.1.By Value (USD Million) 2022-2032F 11.3.2.1.2. Market Share (%) 2022-2032F 11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F 11.3.2.2. Instruments 11.3.2.2.1. By Value (USD Million) 2022-2032F 11.3.2.2.2.Market Share (%) 2022-2032F 11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F 11.3.2.3. Others 11.3.2.3.1. By Value (USD Million) 2022-2032F 11.3.2.3.2.Market Share (%) 2022-2032F 11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F 11.3.3. By End User 11.3.3.1.Diagnostic Laboratory 11.3.3.1.1.By Value (USD Million) 2022-2032F 11.3.3.1.2. Market Share (%) 2022-2032F 11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F 11.3.3.2. Hospital Laboratory 11.3.3.2.1. By Value (USD Million) 2022-2032F 11.3.3.2.2.Market Share (%) 2022-2032F 11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F 11.3.3.3. Point-of-care Testing 11.3.3.3.1. By Value (USD Million) 2022-2032F 11.3.3.3.2.Market Share (%) 2022-2032F 11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F 11.3.3.4. Others 11.3.3.4.1. By Value (USD Million) 2022-2032F 11.3.3.4.2. Market Share (%) 2022-2032F 11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F 12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F 12.1. Overview 12.2. Key Findings 12.3. Market Segmentation 12.3.1. By Test 12.3.2.By Product 12.3.3.By End User 12.4. Country 12.4.1.United States 12.4.2. Canada 13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F 13.1. Overview 13.2. Key Findings 13.3. Market Segmentation 13.3.1. By Test 13.3.2.By Product 13.3.3.By End User 13.4. Country 13.4.1.Germany 13.4.2. United Kingdom 13.4.3. France 13.4.4. Italy 13.4.5. Spain 13.4.6. Russia 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland) 14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F 14.1.Overview 14.2. Key Findings 14.3. Market Segmentation 14.3.1. By Test 14.3.2.By Product 14.3.3.By End User 14.4. Country 14.4.1.India 14.4.2. China 14.4.3. South Korea 14.4.4. Japan 14.4.5. Rest of APAC 15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F 15.1.Overview 15.2. Key Findings 15.3. Market Segmentation 15.3.1. By Test 15.3.2.By Product 15.3.3.By End User 15.4. Country 15.4.1.Israel 15.4.2. GCC 15.4.3. North Africa 15.4.4. South Africa 15.4.5. Rest of Middle East and Africa 16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F 16.1. Overview 16.2. Key Findings 16.3. Market Segmentation 16.3.1. By Test 16.3.2.By Product 16.3.3.By End User 16.4. Country 16.4.1. Mexico 16.4.2. Brazil 16.4.3. Rest of Latin America 17. Competitive Landscape 17.1. Company market share, 2021 17.2.Key player overview 17.3. Key stakeholders 18. Company Profiles 18.1.BioMerieux 18.1.1.Company Overview 18.1.2.Financial Overview 18.1.3.Key Product; Analysis 18.1.4.Company Assessment 18.1.4.1.Product Portfolio 18.1.4.2. Key Clients 18.1.4.3. Market Share 18.1.4.4. Recent News & Development (Last 3 Yrs.) 18.1.4.5. Executive Team 18.2. ARUP Laboratories 18.3. Becton, Dickinson, and Company 18.4.Abbott Laboratories 18.5. Qiagen 18.6. Bio-Reference Laboratories 18.7. Labcorp 18.8.Bioscientia Healthcare 18.9. Danaher Corporation 18.10.Quest Diagnostics Inc. 18.11.Hologic Inc. 18.12.F. Hoffmann-La Roche AG 18.13.Thermo Fisher Scientific 18.14.Sonic Healthcare Ltd 18.15.Sysmex Corporation 18.16. Siemens AG 18.17. Other Prominent Players 19. Appendix 20.Consultant Recommendation 1. Executive Summary 1.1.Regional Market Share 1.2. Business Trends 1.3. Clinical Diagnostics Market: COVID-19 Outbreak 1.4.Regional Trends 1.5. Segmentation Snapshot 2. Research Methodology 2.1. Research Objective 2.2.Research Approach 2.3.Data Sourcing and Methodology 2.4. Primary Research 2.5. Secondary Research 2.5.1.Paid Sources 2.5.2. Public Sources 2.6.Market Size Estimation and Data Triangulation 3. Market Characteristics 3.1. Market Definition 3.2.Clinical Diagnostics Market: COVID-19 Impact 3.3.Key Segmentations 3.4. Key Developments 3.5. Allied Industry Data 4. Clinical Diagnostics Market – Industry Insights 4.1.Industry Segmentation 4.2. COVID-19 overview on world economy 4.3. Industry ecosystem Channel analysis 4.4. Innovation & Sustainability 5. Macroeconomic Indicators 6. Recent Developments 7.Market Dynamics 7.1. Introduction 7.2.Growth Drivers 7.3.Market Opportunities 7.4. Market Restraints 7.5.Market Trends 8. Risk Analysis 9. Market Analysis 9.1. Porters Five Forces 9.2.PEST Analysis 9.2.1. Political 9.2.2.Economic 9.2.3.Social 9.2.4.Technological 10. Clinical Diagnostics Market 10.1.Overview 10.2. Historical Analysis (2016-2021) 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast 11.Clinical Diagnostics Market Size & Forecast 2022A-2032F 11.1.Overview 11.2. Key Findings 11.3. Market Segmentation 11.3.1.By Test 11.3.1.1. Liver Panel 11.3.1.1.1. By Value (USD Million) 2022-2032F 11.3.1.1.2.Market Share (%) 2022-2032F 11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F 11.3.1.2.Lipid Panel 11.3.1.2.1.By Value (USD Million) 2022-2032F 11.3.1.2.2. Market Share (%) 2022-2032F 11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.3.Renal Panel 11.3.1.3.1.By Value (USD Million) 2022-2032F 11.3.1.3.2. Market Share (%) 2022-2032F 11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.4.Electrolyte Testing 11.3.1.4.1.By Value (USD Million) 2022-2032F 11.3.1.4.2. Market Share (%) 2022-2032F 11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.5.Complete Blood Count 11.3.1.5.1.By Value (USD Million) 2022-2032F 11.3.1.5.2. Market Share (%) 2022-2032F 11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.6.Infectious Disease Testing 11.3.1.6.1.By Value (USD Million) 2022-2032F 11.3.1.6.2. Market Share (%) 2022-2032F 11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F 11.3.1.7.Others 11.3.1.7.1.By Value (USD Million) 2022-2032F 11.3.1.7.2. Market Share (%) 2022-2032F 11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F 11.3.2. By Product 11.3.2.1.Reagents 11.3.2.1.1.By Value (USD Million) 2022-2032F 11.3.2.1.2. Market Share (%) 2022-2032F 11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F 11.3.2.2. Instruments 11.3.2.2.1. By Value (USD Million) 2022-2032F 11.3.2.2.2.Market Share (%) 2022-2032F 11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F 11.3.2.3. Others 11.3.2.3.1. By Value (USD Million) 2022-2032F 11.3.2.3.2.Market Share (%) 2022-2032F 11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F 11.3.3. By End User 11.3.3.1.Diagnostic Laboratory 11.3.3.1.1.By Value (USD Million) 2022-2032F 11.3.3.1.2. Market Share (%) 2022-2032F 11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F 11.3.3.2. Hospital Laboratory 11.3.3.2.1. By Value (USD Million) 2022-2032F 11.3.3.2.2.Market Share (%) 2022-2032F 11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F 11.3.3.3. Point-of-care Testing 11.3.3.3.1. By Value (USD Million) 2022-2032F 11.3.3.3.2.Market Share (%) 2022-2032F 11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F 11.3.3.4. Others 11.3.3.4.1. By Value (USD Million) 2022-2032F 11.3.3.4.2. Market Share (%) 2022-2032F 11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F 12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F 12.1. Overview 12.2. Key Findings 12.3. Market Segmentation 12.3.1. By Test 12.3.2.By Product 12.3.3.By End User 12.4. Country 12.4.1.United States 12.4.2. Canada 13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F 13.1. Overview 13.2. Key Findings 13.3. Market Segmentation 13.3.1. By Test 13.3.2.By Product 13.3.3.By End User 13.4. Country 13.4.1.Germany 13.4.2. United Kingdom 13.4.3. France 13.4.4. Italy 13.4.5. Spain 13.4.6. Russia 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland) 14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F 14.1.Overview 14.2. Key Findings 14.3. Market Segmentation 14.3.1. By Test 14.3.2.By Product 14.3.3.By End User 14.4. Country 14.4.1.India 14.4.2. China 14.4.3. South Korea 14.4.4. Japan 14.4.5. Rest of APAC 15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F 15.1.Overview 15.2. Key Findings 15.3. Market Segmentation 15.3.1. By Test 15.3.2.By Product 15.3.3.By End User 15.4. Country 15.4.1.Israel 15.4.2. GCC 15.4.3. North Africa 15.4.4. South Africa 15.4.5. Rest of Middle East and Africa 16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F 16.1. Overview 16.2. Key Findings 16.3. Market Segmentation 16.3.1. By Test 16.3.2.By Product 16.3.3.By End User 16.4. Country 16.4.1. Mexico 16.4.2. Brazil 16.4.3. Rest of Latin America 17. Competitive Landscape 17.1. Company market share, 2021 17.2.Key player overview 17.3. Key stakeholders 18. Company Profiles 18.1.BioMerieux 18.1.1.Company Overview 18.1.2.Financial Overview 18.1.3.Key Product; Analysis 18.1.4.Company Assessment 18.1.4.1.Product Portfolio 18.1.4.2. Key Clients 18.1.4.3. Market Share 18.1.4.4. Recent News & Development (Last 3 Yrs.) 18.1.4.5. Executive Team 18.2. ARUP Laboratories 18.3. Becton, Dickinson, and Company 18.4.Abbott Laboratories 18.5. Qiagen 18.6. Bio-Reference Laboratories 18.7. Labcorp 18.8.Bioscientia Healthcare 18.9. Danaher Corporation 18.10.Quest Diagnostics Inc. 18.11.Hologic Inc. 18.12.F. Hoffmann-La Roche AG 18.13.Thermo Fisher Scientific 18.14.Sonic Healthcare Ltd 18.15.Sysmex Corporation 18.16. Siemens AG 18.17. Other Prominent Players 19. Appendix 20.Consultant Recommendation
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Fatpos Global社のヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(diagnostic)の最新刊レポート
よくあるご質問Fatpos Global社はどのような調査会社ですか?Fatpos Globalは経営コンサルティング、アドバイザリー、市場調査サービスを提供し、市場調査レポートを出版しているインドに主拠点をおく調査会社です。 Fatposは“Failures A... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|